Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-026679
Filing Date
2025-08-14
Accepted
2025-08-14 08:02:45
Documents
91
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clnn20250630_10q.htm   iXBRL 10-Q 2199271
2 EXHIBIT 31.1 ex_829960.htm EX-31.1 12748
3 EXHIBIT 31.2 ex_829961.htm EX-31.2 12513
4 EXHIBIT 32.1 ex_829962.htm EX-32.1 6095
5 EXHIBIT 32.2 ex_829963.htm EX-32.2 6028
11 pipelinejul2025_22pct.jpg GRAPHIC 115805
  Complete submission text file 0001437749-25-026679.txt   11606032

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250630.xsd EX-101.SCH 99146
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clnn-20250630_cal.xml EX-101.CAL 58087
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250630_def.xml EX-101.DEF 608030
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250630_lab.xml EX-101.LAB 561994
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250630_pre.xml EX-101.PRE 651628
94 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250630_10q_htm.xml XML 2253656
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 251214462
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)